Showing results (291-300 of 389) with videos related to

Sort By:
Pageof 39
Investigational New Drugs|March 12, 2013
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancerIsamu Okamoto, Keisuke Aoe, Terufumi Kato, et al.
Anticancer Research|October 3, 2018
Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung CancerShinkichi Takamori, Kazuki Takada, Koichi Azuma, et al.
Translational Lung Cancer Research|July 10, 2023
Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFRnon-small-cell lung cancerMakoto Nishio, Shinji Atagi, Koichi Goto, et al.
The Lancet. Oncology|October 13, 2025
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 studyAkito Hata, Taira Ninomaru, Hideaki Okada, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2023
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitorsHirono Tsutsumi, Hiroyuki Inoue, Yoshimasa Shiraishi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2023
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL StudyRyota Saito, Shunichi Sugawara, Ryo Ko, et al.
Cancer|September 11, 2019
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitorsEiji Iwama, Kazuko Sakai, Noriko Hidaka, et al.
Cancer Research|January 13, 2025
Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination ImmunotherapyToshifumi Ninomiya, Naoya Kemmotsu, Fumiaki Mukohara, et al.
The Oncologist|June 27, 2022
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS StudySatoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2025
A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancerShogo Nomura, Yuta Sekino, Yoshimasa Shiraishi, et al.
Pageof 39